Bioequivalence Study of Brexpiprazole Orally Disintegrating Tablets (ODT) 2mg

Clinical trial NCT03902574 · COMPLETED

Trial details

NCT number: NCT03902574
Sponsor: Otsuka Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Adult Male

Start date: 2019-03-27
Primary completion: 2019-06-18
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.